| NCT ID | NCT02851043 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Nemours Children's Clinic |
| Condition | Neuromuscular Diseases |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2014-08 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2014-08 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will clinically evaluate a newly developed respiratory monitor - pneuRIP. The pneuRIP uses Respiratory Inductance Plethysmography (RIP) bands to measure key breathing indices non-invasively. This study compares the pneuRIP to an existing Respitrace system (Carefusion, Yorba Linda CA). 10 normal children and 10 children with breathing difficulties will be monitored with both systems.
Eligibility Criteria
Inclusion Criteria: * Healthy volunteers * Neuromuscular disease subjects with mild breathing difficulty * Capable of following verbal instructions Exclusion Criteria: * Severe breathing difficulties
Contact & Investigator
Thomas Shaffer, PhD
PRINCIPAL INVESTIGATOR
Nemours
Frequently Asked Questions
Who can join the NCT02851043 clinical trial?
This trial is open to participants of all sexes, aged 11 Years or older, up to 17 Years, studying Neuromuscular Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02851043 currently recruiting?
Yes, NCT02851043 is actively recruiting participants. Contact the research team at trahman@nemours.org for enrollment information.
Where is the NCT02851043 trial being conducted?
This trial is being conducted at Wilmington, United States.
Who is sponsoring the NCT02851043 clinical trial?
NCT02851043 is sponsored by Nemours Children's Clinic. The principal investigator is Thomas Shaffer, PhD at Nemours. The trial plans to enroll 20 participants.